Signia Therapeutics

Re-purposed formulations for influenza infections

placeVilleurbanne, Auvergne Rhone Alpes, France calendar_todayFounded 2017 groups8 employees language signiatherapeutics.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 121 times.

YearFilings
20212
20222
20232

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon